Renal Anaemia

Please note- The EPG Renal Anaemia Knowledge Centre is for Doctors and other Healthcare Professionals.
Enter the Renal Anaemia Knowledge Centre

MIRACEL is the first real-life study to investigate switching the treatment of Chronic Kidney Disease (CKD) patients on dialysis from commonly used shorter-acting erythropoiesis-stimulating agents (ESAs) directly to the once monthly administration of the drug Mircera®, using pre-filled syringes.

Initial results confirm that Mircera® maintains haemoglobin (Hb) levels in CKD patients within a narrow range. Read more about the MIRACEL study results

Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Anaemia in patients with CKD causes debilitating weakness and fatigue, altered cognitive function, and a negative impact on quality of life and wellbeing.1

Renal Anaemia Knowledge Centre

Anaemia is defined as a reduction of the number of circulating red blood cells to below a certain threshold level. It is also described as a low haemoglobin concentration or a low volume of packed red cells2.

Renal anaemia is secondary to chronic kidney disease (CKD) and it appears early in the course of CKD, worsening as it progresses.

Because renal anaemia impairs the delivery and utilization of oxygen to tissues and organs throughout the body, it has a wide range of effects on both quality of life and overall health and well being.2

CKD-related anaemia is a major public health concern. It is associated with an increased risk of morbidity, mortality and hospitalisation, diminished physical well-being and reduced patient quality of life.3-6

Diagnosing renal anaemia is critical in establishing early and appropriate treatment in patients.

The priority in the treatment of anaemia is to correct the underlying factors that caused the anaemia and the specific treatment strategy depends on the cause of the anaemia.

There are a number of treatment guidelines available which provide information on the management of anaemia and CKD related anaemia. Treatment of renal anaemia can significantly improve overall health in patients with chronic kidney disease (CKD).

Enter the Renal Anaemia Knowledge Centre

What’s in the Renal Anaemia Knowledge Centre?

References:
1. Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin. 2006;22:1929-1937.
2. NAAC (National Anemia Action Council) Anemia monograph. Available at http://anemia.org/professionals/monograph/ [Accessed June 2008].
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53–61.
4. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34:125–134.
5. Ofsthun N, Labrecque J, Lacson E, Keen M, Lazarus JM. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int. 2003;63:1908–1914.
6. Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658–666.

Related Urological and Kidney Diseases Information

Urological and Kidney Diseases Clinical Guidelines

Diagnosis and management of chronic kidney disease

Scottish Intercollegiate Guidelines Network (SIGN)

Early identification and management of chronic kidney disease in adults in primary and secondary care

National Institute for Health and Care Excellence (NICE)

Urological and Kidney Diseases Clinical Trials

Phase III Radium 223 mCRPC-PEACE III

Clinicaltrials.gov 17 July 2014

Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating Women

Clinicaltrials.gov 09 July 2014

Urological and Kidney Diseases Medical Journal Abstracts

Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies

International Journal of Urology 15 April 2014

Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection

International Journal of Urology 13 April 2014

Urological and Kidney Diseases Medical Apps

ESMO Cancer Guidelines

Free

ESMO Cancer Guidelines par European Society for Medical Oncology

Free

Urological and Kidney Diseases News

SOBI files Xiapex at EU to treat Peyronie's disease.

26 Jun 2014

Positive safety studies for NX 1207 for BPH - Nymox Pharma

13 Jun 2014

Related Urological and Kidney Diseases Drugs

Back to top

Latest News

26 Jun 2014
13 Jun 2014
29 May 2014